Navigation Links
InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
Date:9/25/2007

Ablate technology and clinical experience can be found at http://www.insightec.com. Details about the clinical trial can also be found at Clinical Trials.gov (http://www.clinicaltrials.gov/ct/show/NCT00147056;jsessionid= DA645CDD9781968B8BF5161676409C8B?order=4)

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About ExAblate

The ExAblate(r) is the first system to use the breakthrough MRgFUS technology that combines MRI - to visualize tissues in the body, plan the treatment and monitor in real time treatment outcome - and high intensity focused ultrasound to thermally ablate uterine fibroid tissue. MR thermal feedback, provided uniquely by the system, allows the physician to control and adjust the treatment in real time to ensure that the targeted tumor is fully treated and surrounding tissue is spared. ExAblate received FDA approval for the treatment of symptomatic uterine fibroids in October 2004. ExAblate has been recognized for its innovation and potential to serve mankind and has been awarded the 2004 European Union's Information Society Technologies grand prize, The Wall Street Journal's 2004 Technology Innovation Awards, Advanced Imaging's 2005 Solutions of the Year and, the Red Herring 100 Europe 2007 Award.

About InSightec

InSightec Ltd. is a privately held company owned by Elbit Medical Imaging (EMI), General Electric, MediTech Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 135 employees and has invested more than $100 million in research, development, and clinical investigations. Its U.S. headquarters
'/>"/>

SOURCE InSightec Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...secondhand smoke, an estimated ten percent of preg... developing baby to harmful cigarette byproducts f... newborns each year and poses a significant health...ind, a team of researchers has completed a global ...tter understand the fetal health risks from smokin...
(Date:12/3/2008)...stCall/ -- GlaxoSmithKline,(LSE/NYSE: GSK ) ann...ng to a,pending lawsuit in the previously announc...g shares of common stock of Genelabs Technologies,...ash without interest and less any,required withho...pletion of the tender offer that there not be,any...
(Date:12/3/2008)...Cellectricon, a leading,provider of screening sol...gning of a collaborative agreement with The Automa...f advanced automated systems for cell culture, sam...ications. Under the agreement,TAP will co-develop...ricon,s,next generation high throughput ion chann...
(Date:12/3/2008)...ogy Can Solve Pressing Food, Fuel Problems of...3 /PRNewswire/ - Dr. David Dennis, FRSC, CEO of Pe...g experts speaking at a side event at the United N...n , Poland. Dr. Dennis will outline how technology...e role it will play in solving today,s pressing is...
Breaking Biology Technology:Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 2Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 3Leading Canadian Scientist to speak at UN Climate Change Conference 2
... the University of Wisconsin-Eau Claire are poolin...ities to work on research relating to materials sc... assist local industries. , ,UW-Eau Claires newly ...arch, facilitate collaboration among science facul...n the university and local industries, and encoura...
... are concerned with the increasing trade imbalance...nd begin the process of leveling the playing field...em! , ,As developing nations rush to play catch-u...ten doled out as favors, to friends in high places... This occurred in Japan during the 1990s and it ha...
...ttachments containing sensitive corporate informat...were sent in error, stored on a stolen notebook co...equences can be embarrassing and costly. Serious l...ty may result from access to this type of informat...tems recently introduced a new solution to protect...
...s and Madison-based MyWeather LLC announced tod...s for breaking news and severe weather, has surpas... stations. , ,Powered by MyWeather technology, Des...on to people while they are at work, away from the...to proactively grab viewers attention, alerting th...
Other Biology Technology:UW-Eau Claire creates Materials Science Center 2UW-Eau Claire creates Materials Science Center 3How do you level the playing field with China? 2How do you level the playing field with China? 3New solution protects corporate information 2
(Date:12/3/2008)...t is a well-known fact in drug trials that individ...ills, as to the active drug. On the other hand, i...get better from placebos. A team of researchers f...ave now found gene variants that can impact the pl...racterizes those who respond to placebos. , The ...
(Date:12/3/2008)...ased on the outstanding success of the first tande... has paired the two satellites together again to h...RS-2, ESA,s veteran spacecraft, and Envisat, the l...rry Synthetic Aperture Radar (SAR) instruments tha...rface. ,By combining two or more SAR images of ...
(Date:12/3/2008)...he conference will take place December 14-17, 2008...n the Negev under the auspices of BGU,s Jacob Blau...g the co-sponsors of the conference are the United...nization (UNESCO), Israel,s Ministry for Foreign A...Tel Aviv, and Netafim, the global leader in smart ...
(Date:12/3/2008)...hevy Chase, MDDiets that are high in protein and c... which may increase calcium excretion and weaken b...ation in The Endocrine Society,s Journal of Clini...y found that increasing the alkali content of the ... and vegetables has the opposite effect and streng...
Breaking Biology News(10 mins):Genes determine whether sugar pills work 2ESA satellites flying in formation 2Ben-Gurion University of the Negev to host 2Calcium and vitamin D may not be the only protection against bone loss 23 Common Drugs Trigger Most ER Visits by Seniors 7496 13 Common Drugs Trigger Most ER Visits by Seniors 7496 2Tis the Season to be Jolly and Stress Free 3A Survey Reveals Womens Stress Levels During the Holidays 7494 1Tis the Season to be Jolly and Stress Free 3A Survey Reveals Womens Stress Levels During the Holidays 7494 2Mayo Clinics Dr Ronald C Petersen Awarded Leon Thal Prize for Excellence in Dementia Research 7492 1Mayo Clinics Dr Ronald C Petersen Awarded Leon Thal Prize for Excellence in Dementia Research 7492 2University Hospital of Bordeaux Officially Opens New Electrophysiology Lab 7490 1University Hospital of Bordeaux Officially Opens New Electrophysiology Lab 7490 2University Hospital of Bordeaux Officially Opens New Electrophysiology Lab 7490 3
...rgic reactions? A new study in the February 21 iss...me of the blame on bioactive molecules that are re... cells and cause them to launch a typical allergy-...sed to air pollutants produce more of these allerg...ed areas, possibly explaining why allergies are mo...
...teins,bind to DNA and identifying the genes they r...hnique developed by scientists at the U.S.,Departm...e technique,could greatly speed the process of unr... and off the genes that establish the very identit...as well as what might,go awry in certain condition...
...ping a,vaccine against HIV infection have been giv... the Global HIV/AIDS Vaccine Enterprise,s,scientif...available,open-access global health journal PLoS ...s an international alliance of,independent agencie...accine research. In June 2004, the G8 countries en...
...a “cautionary tale?about what may go wrong when us...a diagnostic test for cancer. , In the February 1...itute, researchers from The University of Texas M....tal test intended to identify early ovarian cancer...to a reliable clinical test right away. , After c...
Other Biology News:New Technique for Tracking Gene Regulators 2New Technique for Tracking Gene Regulators 3A much-needed shot in the arm for HIV vaccine development 2A much-needed shot in the arm for HIV vaccine development 3Signaling protein builds bigger, better bones in mice 2Signaling protein builds bigger, better bones in mice 3
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU.
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications).
...cks specificially with the ovine CRF sequence that... in the paraventricular hypothalamic nucleus of ra...e. Immunogen: CRF: Ser-Gln-Glu-Pro-Pro-Ile-Ser...lu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His...
siSolutions siRNA Custom Synthesis Service provides you with high-quality, effective duplex RNA to knockdown any gene. We offer standard 21-mers (19 RNA base pairs with terminal dT nucleotides), the
Biology Products: